During the past decade, Kinghorn Cancer Centre; St Vincents Hospital conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 4 clinical trials were completed, i.e. on average, 28.6% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 1 clinical trials were completed. i.e. 20% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kinghorn Cancer Centre; St Vincents Hospital" #1 sponsor was "Hoffmann-La Roche" with 6 trials, followed by "Arcus Biosciences, Inc." with 3 trials sponsored, "Genentech, Inc." with 2 trials sponsored, "Bayer" with 1 trials sponsored and "OncoMed Pharmaceuticals, Inc." with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kinghorn Cancer Centre; St Vincents Hospital" #1 collaborator was "Austrian Breast and Colorectal Cancer Group" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "Celgene Corporation" with 1 trials as a collaborator, "Gilead Sciences" with 1 trials as a collaborator and "ImmunoGen, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Kinghorn Cancer Centre; St Vincents Hospital" are "Breast Cancer" (3 trials), "Ovarian Cancer" (2 trials), "Advanced Solid Tumors" (1 trials), "Advanced/Metastatic Tumors" (1 trials) and "Colorectal Cancer" (1 trials). Many other conditions were trialed in "Kinghorn Cancer Centre; St Vincents Hospital" in a lesser frequency.

Most popular intervention types in "Kinghorn Cancer Centre; St Vincents Hospital" are "Drug" (14 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (3 trials), "Alectinib" (2 trials), "Carboplatin" (2 trials), "Cisplatin" (2 trials) and "Giredestrant" (2 trials). Other intervention names were less common.

The vast majority of trials in "Kinghorn Cancer Centre; St Vincents Hospital" are 12 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Kinghorn Cancer Centre; St Vincents Hospital". undefined are not yet recruiting, 2 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Kinghorn Cancer Centre; St Vincents Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Kinghorn Cancer Centre; St Vincents Hospital, 7 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

Kinghorn Cancer Centre; St Vincents Hospital has several departments that took part in Clinical trials: "Kinghorn Cancer Centre, St. Vincent's Hospital" - 4 trials